Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
ABC
absolute neutrophil count (ANC) Answer 3.2 Question 3.2 Answer 11.4 Answer 3.5
ACTH
acute kidney injury (AKI) Question 3.4 Antifolate Toxicities and Supportive Agents
acute lymphoblastic leukemia (ALL) Asparaginases, as Amidohydrolases, Possess Both Asparaginase and Glutaminase Activity Polymorphism in Thiopurine Methyltransferase (TPMT) Question 3.6 Question 5.2 Answer 5.2 Immunotherapeutics Including Vaccines, Bispecifics, CAR-T, and Checkpoint Inhibitors Purine Analogs Question 3.7
acute myeloid leukemia (AML) Question 15.3 Question 15.1 Targeted Therapies (Small Molecules)
acute promyelocytic leukemia (APL) Differentiating Agents and Microenvironment Question 8.1
acute respiratory distress syndrome (ARDS)
ADC
ADCP
adenosine triphosphate (ATP) Targeted Therapies (Small Molecules) Tyrosine Kinase Inhibitors (TKI)
adoptive T-cell therapies (ACT)
adrenocorticotropic hormone (ACTH) Male Hormonal Therapies Chemical Structures of Abiraterone and its Prodrug, Abiraterone Acetate Sources of and rogens in the Human Prostate
ADT
AE
AKI
alanine transaminase (ALT)
ALDH
Alkylating agents cyclophosphamide and ifosfamide methylguanine methyltransferase, clinical importance platinum compounds triazines (three attached nitrogen atoms) ethylenimines nitrosoureas treatment goal
allo-hematopoietic stem cell transplantation (HSCT) Answer 15.3 Answer 15.5 Answer 15.4 Question 15.1 Question 15.3 Transplant-Related Agents Mechanism of Action of High-Dose Cyclophosphamide Graft-Versus-Host Disease (GVHD) Prophylaxis Question 15.2 Question 15.4
About
ACT
ADA
ADCC
adenosine deaminase (ADA)
adverse effect (AE)
AIs
alanine aminotransferase (ALT)
aldehyde dehydrogenase (ALDH)
ALK

NDX